Showing posts with label Digital Therapeutics Market Size. Show all posts
Showing posts with label Digital Therapeutics Market Size. Show all posts

Monday, 29 November 2021

Latest Digital Therapeutics Market Trend, Growth By Size, Application And Forecast

 The report “Global Digital Therapeutics Market Growth 2021-2028” from PMR Market Research includes data and information about market structure and size. The purpose of this research is to give market knowledge and strategic insights to assist in decision making, making informed investment decisions, and identifying potential growth opportunities.

 

The research report adopts primary and secondary research approaches, resulting in a precise and accurate insight into the Digital Therapeutics industry. To examine the segments and provide a fair assessment of their influence on the worldwide market, analysts utilized a top-down and bottom-up strategy. The study begins with a market overview, which includes a brief description of the industry's current state as well as the major segments. It also lists the leading players in the global market.


Download FREE Sample Copy :  https://www.polarismarketresearch.com/industry-analysis/digital-therapeutics-market/request-for-sample


A Porter's five forces analysis and SWOT analysis are included in the research study on the global Digital Therapeutics market, which empower to determine the market's accurate trajectory. Such effective market analysis tools helps to identify market’s major drivers, restraints, risks, and market opportunities. In addition to this, the research report also features statistics for global market as well as different regional markets. 


Market Segmentation 

The report features in-depth segmentation and sub-segmentation of the target market. The executive summary of the Digital Therapeutics market research provides a quick overview of the market. It discusses the key sectors and companies projected to shape the market in the coming years. The executive summary provides a non-biased view of the market. It describes how the market's demand and supply will be affected by shifting demographics. It goes over the regulatory adjustments that are expected to change people's buying behavior.


Exclusive Discount Offer on this Research Report :   https://www.polarismarketresearch.com/industry-analysis/digital-therapeutics-market/request-for-discount-pricing


COVID-19 Pandemic Impact Analysis

This Digital Therapeutics market study discusses the impact of the COVID-19 pandemic on macro and micro aspects of business, hurdles encountered by each sector, and continuous efforts to turn this crisis into an opportunity. The research report also discusses government policies for recovering the economy in detail, in order to assist businesses in expanding or entering new markets, as well as introducing new products and services.


Competitive Analysis

This section of the research study focuses on the market's leading players and competitive landscape. The Digital Therapeutics market study provides a list of strategic efforts undertaken by companies in recent years, as well as those anticipated in the near future. The financial prospects of these companies, their research and development activities, and their expansion plans for the near future have all been noted by researchers. The global market research report is a serious endeavor to provide interested readers with a thorough view of the market.


Market participants such as 2Morrow, Inc., Akili Interactive Labs, Ayogo Health Inc., Better Therapeutics, Inc., Canary Health Inc., Click Therapeutics, Inc., Cognoa, Inc., Ginger, Kaia Health Software GmbH, Livongo Health Inc, Mango Health, Inc., Mindstrong Inc., Noom Health, Inc., Omada Health, Inc., Otsuka America Pharmaceutical, Inc., Pear Therapeutics, Inc., Propeller Health, WellDoc, Inc., and Wellthy Therapeutics are some of the companies operating in the market for digital therapeutics.


Key Reason to buy this Digital Therapeutics Market Research Report

  • It provides analytical data along with strategic planning approaches to help businesses make informed decisions.


  • The market's dynamics, such as drivers, restraints, trends, and opportunities, are examined by researchers.

 

  • It provides a wealth of information on current events that will have an impact on the market's overall performance. 

 

  • It includes regional analysis of the global market as well as corporate profiles of various stakeholders.

 

Read  More :

https://www.prnewswire.com/news-releases/hydrogen-peroxide-market-size-worth-2-11-billion-by-2028--cagr-5-8--polaris-market-research-301420882.html

https://www.prnewswire.com/news-releases/smart-cities-market-size-to-reach-1-03-trillion-by-2028--cagr-14-4-exclusive-report-by-polaris-market-research-301421024.html

https://www.prnewswire.com/news-releases/track-and-trace-solutions-market-size-is-projected-to-reach-9-33-billion-by-2028--cagr-18-9-polaris-market-research-301421006.html

 

 

Tuesday, 12 October 2021

Digital Therapeutics Market With Business Strategies And Analysis To 2028

 Digital Therapeutics The global digital therapeutics market size is expected to reach USD 13.51 billion by 2028 according to a new study by Polaris Market Research. The report “Global Digital Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Application (Diabetes, Obesity, CVD, CNS Disease, Respiratory Diseases, Smoking Cessation, Others), By End-Use (Patients, Providers, Payers, Employers, Others), By Regions; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The distinction between digital therapeutics is determined by patient clinical outcomes. Digital therapeutics do not use market-based health-related instruments like step and calorie-counters. It is a modern form of healthcare product that utilizes digital technologies to avoid, handle, and health ailments. Furthermore, it makes use of emerging health technology to treat the psychiatric ailment. As a result, the aforementioned factors contribute to the growth of the target market share.

 

During the year 2020, digital health went from innovation to need. As acceptance peaked, exacerbated by the COVID-19 pandemic, it swept into almost every healthcare domain. Telehealth, digital pathology, triage solutions, telemedicine, mhealth, and digital therapeutics were among the topics discussed.

 

Request for sample of this research report @ https://www.polarismarketresearch.com/industry-analysis/digital-therapeutics-market/request-for-sample

 

Digital Therapeutics Market Analysis & Segment Forecast till 2028

Omada Health, Inc., took advantage of the shortages in treatment caused by COVID-19 to offer additional help and advice through its dedicated practitioners to those whose doctor’s appointments had been postponed indefinitely.

 

Additionally, the organization assisted primary care practitioners, psychiatrists, endocrinologists, and cardiologists in converting their practices to telehealth through providing improved knowledge, psychosocial support, and an online platform.

 

Market participants such as 2Morrow, Inc., Akili Interactive Labs, Ayogo Health Inc., Better Therapeutics, Inc., Canary Health Inc., Click Therapeutics, Inc., Cognoa, Inc., Ginger, Kaia Health Software GmbH, Livongo Health Inc, Mango Health, Inc., Mindstrong Inc., Noom Health, Inc., Omada Health, Inc., Otsuka America Pharmaceutical, Inc., Pear Therapeutics, Inc., Propeller Health, WellDoc, Inc., and Wellthy Therapeutics are some of the companies operating in the market for digital therapeutics.

 

The FDA issued recommendations extending and encouraging the scope of digital health therapeutics technologies for mental health issues in response to COVID-19 and its ramifications on mental health. Another factor expected to drive demand growth is increased public and private sector initiatives. For example, Akili Interactive Labs, Inc. obtained the CE mark for EndeavorRx, its digital therapeutics software for the treatment of ADHD, in June 2020.

 

Get Exclusive Discount on This Report @ https://www.polarismarketresearch.com/industry-analysis/digital-therapeutics-market/request-for-discount-pricing

 

Digital therapeutics is anticipated to rise at a steady pace in the given timeframe, due to strong internet usage and reliance on smartphones. This is due to a rise in demand for creative and innovative treatment solutions that patients can access remotely.

 

In February 2021, SilverCloud and Cerner Corporation collaborated to combine SilverCloud’s virtual mental health network with Cerner’s electronic health records. SilverCloud hoped that by doing so, it would be able to scale the delivery of evidence-based mental health services while both enhancing patient outcomes and lowering healthcare costs.

 

Polaris Market Research has segmented the digital therapeutics market report based on application, end-use, and region:

 

Digital Therapeutics, Application Outlook (Revenue – USD Billion, 2016 – 2028)

  • Diabetes
  • Obesity
  • CVD
  • CNS Disease
  • Respiratory Diseases
  • Smoking Cessation
  • Others

Digital Therapeutics, End-Use Outlook (Revenue – USD Billion, 2016 – 2028)

  • Patients
  • Providers
  • Payers
  • Employers
  • Others

Read :

https://www.prnewswire.com/news-releases/terminal-sterilization-services-market-size-to-reach-18-97-billion-by-2028--cagr-10-4-polaris-market-research-301387749.html

https://www.prnewswire.com/news-releases/food-waste-management-market-size-worth-54-29-billion-by-2028--cagr-5-6-polaris-market-research-301387793.html

 

Wednesday, 29 September 2021

Digital Therapeutics Market Size, Recent Advancement & Scope Top Trends

 PDF :  Digital Therapeutics Market  2021 – 2028 


The global digital therapeutics market size is expected to reach USD 13.51 billion by 2028 according to a new study by Polaris Market Research. The report “Global Digital Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Application (Diabetes, Obesity, CVD, CNS Disease, Respiratory Diseases, Smoking Cessation, Others), By End-Use (Patients, Providers, Payers, Employers, Others), By Regions; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth. 

 

The distinction between digital therapeutics is determined by patient clinical outcomes. Digital therapeutics do not use market-based health-related instruments like step and calorie-counters. It is a modern form of healthcare product that utilizes digital technologies to avoid, handle, and health ailments. Furthermore, it makes use of emerging health technology to treat the psychiatric ailment. As a result, the aforementioned factors contribute to the growth of the target market share.

 

During the year 2020, digital health went from innovation to need. As acceptance peaked, exacerbated by the COVID-19 pandemic, it swept into almost every healthcare domain. Telehealth, digital pathology, triage solutions, telemedicine, mhealth, and digital therapeutics were among the topics discussed.

 

Request for sample of this research report @ https://www.polarismarketresearch.com/industry-analysis/digital-therapeutics-market/request-for-sample

 

Omada Health, Inc., took advantage of the shortages in treatment caused by COVID-19 to offer additional help and advice through its dedicated practitioners to those whose doctor’s appointments had been postponed indefinitely.

 

Additionally, the organization assisted primary care practitioners, psychiatrists, endocrinologists, and cardiologists in converting their practices to telehealth through providing improved knowledge, psychosocial support, and an online platform.

 

Market participants such as 2Morrow, Inc., Akili Interactive Labs, Ayogo Health Inc., Better Therapeutics, Inc., Canary Health Inc., Click Therapeutics, Inc., Cognoa, Inc., Ginger, Kaia Health Software GmbH, Livongo Health Inc, Mango Health, Inc., Mindstrong Inc., Noom Health, Inc., Omada Health, Inc., Otsuka America Pharmaceutical, Inc., Pear Therapeutics, Inc., Propeller Health, WellDoc, Inc., and Wellthy Therapeutics are some of the companies operating in the market for digital therapeutics.

 

The FDA issued recommendations extending and encouraging the scope of digital health therapeutics technologies for mental health issues in response to COVID-19 and its ramifications on mental health. Another factor expected to drive demand growth is increased public and private sector initiatives. For example, Akili Interactive Labs, Inc. obtained the CE mark for EndeavorRx, its digital therapeutics software for the treatment of ADHD, in June 2020.

 

Get Exclusive Discount on This Report @ https://www.polarismarketresearch.com/industry-analysis/digital-therapeutics-market/request-for-discount-pricing 

 

Digital therapeutics is anticipated to rise at a steady pace in the given timeframe, due to strong internet usage and reliance on smartphones. This is due to a rise in demand for creative and innovative treatment solutions that patients can access remotely.

 

In February 2021, SilverCloud and Cerner Corporation collaborated to combine SilverCloud’s virtual mental health network with Cerner’s electronic health records. SilverCloud hoped that by doing so, it would be able to scale the delivery of evidence-based mental health services while both enhancing patient outcomes and lowering healthcare costs.

 

Polaris Market Research has segmented the digital therapeutics market report based on application, end-use, and region:

 

Digital Therapeutics, Application Outlook (Revenue – USD Billion, 2016 – 2028)

  • Diabetes
  • Obesity
  • CVD
  • CNS Disease
  • Respiratory Diseases
  • Smoking Cessation
  • Others

Digital Therapeutics, End-Use Outlook (Revenue – USD Billion, 2016 – 2028)

  • Patients
  • Providers
  • Payers
  • Employers
  • Others

 

Thursday, 2 September 2021

Digital Therapeutics Market With Business Strategies And Analysis To 2028

 The global digital therapeutics market size is expected to reach USD 13.51 billion by 2028 according to a new study by Polaris Market Research. The report “Global Digital Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Application (Diabetes, Obesity, CVD, CNS Disease, Respiratory Diseases, Smoking Cessation, Others), By End-Use (Patients, Providers, Payers, Employers, Others), By Regions; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.

 

 

The distinction between digital therapeutics is determined by patient clinical outcomes. Digital therapeutics do not use market-based health-related instruments like step and calorie-counters. It is a modern form of healthcare product that utilizes digital technologies to avoid, handle, and health ailments. Furthermore, it makes use of emerging health technology to treat the psychiatric ailment. As a result, the aforementioned factors contribute to the growth of the target market share.

 

During the year 2020, digital health went from innovation to need. As acceptance peaked, exacerbated by the COVID-19 pandemic, it swept into almost every healthcare domain. Telehealth, digital pathology, triage solutions, telemedicine, mhealth, and digital therapeutics were among the topics discussed.

 

Request for sample of this research report @ https://www.polarismarketresearch.com/industry-analysis/digital-therapeutics-market/request-for-sample

 

Omada Health, Inc., took advantage of the shortages in treatment caused by COVID-19 to offer additional help and advice through its dedicated practitioners to those whose doctor’s appointments had been postponed indefinitely.

 

Additionally, the organization assisted primary care practitioners, psychiatrists, endocrinologists, and cardiologists in converting their practices to telehealth through providing improved knowledge, psychosocial support, and an online platform.

 

Market participants such as 2Morrow, Inc., Akili Interactive Labs, Ayogo Health Inc., Better Therapeutics, Inc., Canary Health Inc., Click Therapeutics, Inc., Cognoa, Inc., Ginger, Kaia Health Software GmbH, Livongo Health Inc, Mango Health, Inc., Mindstrong Inc., Noom Health, Inc., Omada Health, Inc., Otsuka America Pharmaceutical, Inc., Pear Therapeutics, Inc., Propeller Health, WellDoc, Inc., and Wellthy Therapeutics are some of the companies operating in the market for digital therapeutics.

 

The FDA issued recommendations extending and encouraging the scope of digital health therapeutics technologies for mental health issues in response to COVID-19 and its ramifications on mental health. Another factor expected to drive demand growth is increased public and private sector initiatives. For example, Akili Interactive Labs, Inc. obtained the CE mark for EndeavorRx, its digital therapeutics software for the treatment of ADHD, in June 2020.

 

Get Exclusive Discount on This Report @ https://www.polarismarketresearch.com/industry-analysis/digital-therapeutics-market/request-for-discount-pricing 

 

Digital therapeutics is anticipated to rise at a steady pace in the given timeframe, due to strong internet usage and reliance on smartphones. This is due to a rise in demand for creative and innovative treatment solutions that patients can access remotely.

 

In February 2021, SilverCloud and Cerner Corporation collaborated to combine SilverCloud’s virtual mental health network with Cerner’s electronic health records. SilverCloud hoped that by doing so, it would be able to scale the delivery of evidence-based mental health services while both enhancing patient outcomes and lowering healthcare costs.

 

Polaris Market Research has segmented the digital therapeutics market report based on application, end-use, and region:

 

Digital Therapeutics, Application Outlook (Revenue – USD Billion, 2016 – 2028)

  • Diabetes
  • Obesity
  • CVD
  • CNS Disease
  • Respiratory Diseases
  • Smoking Cessation
  • Others

Digital Therapeutics, End-Use Outlook (Revenue – USD Billion, 2016 – 2028)

  • Patients
  • Providers
  • Payers
  • Employers
  • Others